![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, February 24, 2012 10:10:23 AM
Kraig Biocraft Laboratories to Host Shareholder Conference Call, Regarding Product, Scientific and Commercialization Developments
LANSING, MI--(Marketwire - Dec 2, 2011) - Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (PINKSHEETS: KBLB) announces that the Company will host an upcoming conference call to discuss product, scientific and commercialization developments. The conference call schedule is being worked around the holiday and is tentatively scheduled for the first or second week of January, and will feature the Company's founder and CEO, Kim Thompson.
The Company recently announced that it has succeeded in creating seven new strains of genetically modified silkworm using zinc finger nuclease technology. Those new transgenics are expected to become the basis for the Company's new platform technology.
"The pace of discovery and invention in the laboratory has been accelerating due to our successful integration of zinc finger technologies," said Thompson.
"We are eager to update our textile and business community as to these developments and what they mean for our commercialization pipeline. We will also discuss significant commercialization and corporate developments, and strategies for the coming year."
Additional topics include the recent breakthrough with zinc finger nuclease technology, as well as the status of other second generation spider-silk developments.
The Company will release the conference call details, including time, date and medium, in an upcoming Company release.
Shareholders are invited to submit questions to benh@ttfsco.com.
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM